CX Institutional’s Northern Trust NTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
1,549
+44
+3% +$7.25K 0.01% 673
2026
Q1
$210K Buy
1,505
+16
+1% +$2.3K 0.01% 705
2025
Q4
$203K Buy
1,489
+118
+9% +$15.5K 0.01% 708
2025
Q3
$185K Sell
1,371
-18
-1% -$2.32K 0.01% 712
2025
Q2
$176K Buy
1,389
+420
+43% +$42.9K 0.01% 669
2025
Q1
$96K Buy
+969
New +$103K ﹤0.01% 755
2022
Q3
Sell
-707
Closed -$68K 915
2022
Q2
$68K Buy
+707
New +$74.7K 0.01% 615
2021
Q4
Sell
-740
Closed -$80K 729
2021
Q3
$80K Buy
740
+16
+2% +$1.82K 0.01% 488
2021
Q2
$84K Buy
724
+73
+11% +$8.37K 0.01% 465
2021
Q1
$68K Sell
651
-106
-14% -$10.4K 0.01% 428
2020
Q4
$71K Buy
757
+107
+16% +$9.44K 0.01% 398
2020
Q3
$51K Sell
650
-181
-22% -$14.5K 0.01% 382
2020
Q2
$66K Buy
831
+201
+32% +$15.9K 0.01% 320
2020
Q1
$48K Sell
630
-99
-14% -$9.08K 0.01% 316
2019
Q4
$77K Sell
729
-272
-27% -$27.8K 0.01% 252
2019
Q3
$93K Buy
1,001
+5
+0.5% +$459 0.02% 254
2019
Q2
$90K Sell
996
-1,340
-57% -$123K 0.01% 283
2019
Q1
$211K Buy
+2,336
New +$211K 0.04% 210

Other funds holding NTRS

CX Institutional's NTRS Position: Q2 2026 in Review

CX Institutional increased its Northern Trust (NTRS) stake by 2.9% in Q2 2026, buying an estimated $7.25K and bringing the position to 1,549 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #673.

CX Institutional first reported a position in NTRS in Q1 2019 and has held it in 18 quarters since. 1,019 funds tracked by Wall St. Rank hold NTRS as of Q2 2026.

  • CX Institutional held 1,549 shares of Northern Trust worth $269K as of Q2 2026.
  • CX Institutional bought 44 Northern Trust shares in Q2 2026, an estimated $7.25K.
  • Northern Trust made up 0.01% of CX Institutional's portfolio in Q2 2026, its #673 holding.
  • CX Institutional first reported a position in Northern Trust in Q1 2019 and has held it in 18 quarters since.
  • 1,019 funds tracked by Wall St. Rank held Northern Trust as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.